MIMEDX to Participate in Upcoming Investor Conferences
MiMedx (Nasdaq: MDXG) announced that senior management will participate in two investor conferences in New York in November 2025.
Key details: Craig-Hallum 16th Annual Alpha Select Conference in New York on Tuesday, November 18, 2025 with 1:1 sessions, and Canaccord MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 20, 2025 with 1:1 sessions. Investors seeking meetings should contact their Craig-Hallum or Canaccord representative.
MiMedx (Nasdaq: MDXG) ha annunciato che i vertici aziendali parteciperanno a due conferenze per investitori a New York nel novembre 2025.
Dettagli chiave: Craig-Hallum 16ª Alpha Select Conference a New York martedì 18 novembre 2025 con sessioni 1:1, e Canaccord MedTech, Diagnostics and Digital Health & Services Forum a New York giovedì 20 novembre 2025 con sessioni 1:1. Gli investitori interessati a incontrarsi dovrebbero contattare il rappresentante di Craig-Hallum o di Canaccord.
MiMedx (Nasdaq: MDXG) anunció que la alta dirección participará en dos conferencias para inversores en Nueva York en noviembre de 2025.
Detalles clave: Craig-Hallum 16th Annual Alpha Select Conference en Nueva York el martes 18 de noviembre de 2025 con sesiones 1:1, y Canaccord MedTech, Diagnostics and Digital Health & Services Forum en Nueva York el jueves 20 de noviembre de 2025 con sesiones 1:1. Los inversores interesados en reuniones deben ponerse en contacto con su representante de Craig-Hallum o de Canaccord.
MiMedx (Nasdaq: MDXG)는 2025년 11월 뉴욕에서 열리는 두 차례의 투자자 컨퍼런스에 시니어 매니지먼트가 참석할 것이라고 발표했습니다.
주요 일정: Craig-Hallum 16th Annual Alpha Select Conference가 2025년 11월 18일 화요일 뉴욕에서 1:1 세션으로 진행되며, Canaccord MedTech, Diagnostics and Digital Health & Services Forum가 2025년 11월 20일 목요일 뉴욕에서 1:1 세션으로 진행됩니다. 회의를 원하시는 투자자께서는 Craig-Hallum 또는 Canaccord 담당자에게 연락하시기 바랍니다.
MiMedx (Nasdaq: MDXG) a annoncé que la direction générale participera à deux conférences pour investisseurs à New York en novembre 2025.
Points clés : Craig-Hallum 16th Annual Alpha Select Conference à New York le mardi 18 novembre 2025 avec des séances individuelles, et Canaccord MedTech, Diagnostics and Digital Health & Services Forum à New York le jeudi 20 novembre 2025 avec des séances 1:1. Les investisseurs souhaitant obtenir des rendez-vous doivent contacter leur représentant Craig-Hallum ou Canaccord.
MiMedx (Nasdaq: MDXG) hat angekündigt, dass das obere Management an zwei Investorenkonferenzen in New York im November 2025 teilnehmen wird.
Wesentliche Details: Craig-Hallum 16th Annual Alpha Select Conference in New York am Dienstag, dem 18. November 2025, mit 1:1-Sitzungen, und Canaccord MedTech, Diagnostics and Digital Health & Services Forum in New York am Donnerstag, dem 20. November 2025, mit 1:1-Sitzungen. Investoren, die Meetings wünschen, sollten sich an ihren Craig-Hallum- oder Canaccord-Vertreter wenden.
MiMedx (Nasdaq: MDXG) أعلنت أن الإدارة العليا ستشارك في مؤتمريْن للمستثمرين في نيويورك في نوفمبر 2025.
تفاصيل رئيسية: مؤتمر Craig-Hallum السنوي الساد عشر Alpha Select Conference في نيويورك يوم الثلاثاء 18 نوفمبر 2025 مع جلسات 1:1، ومنتدى Canaccord MedTech, Diagnostics and Digital Health & Services Forum في نيويورك يوم الخميس 20 نوفمبر 2025 مع جلسات 1:1. المستثمرون الراغبون في الاجتماعات يجب أن يتصلوا بممثل Craig-Hallum أو Canaccord.
- None.
- None.
MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Craig-Hallum 16th Annual Alpha Select Conference | New York, NY
Tuesday, November 18, 2025
1:1 sessions
Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NY
Thursday, November 20, 2025
1:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Craig-Hallum or Canaccord representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com